Today’s article is about the newest cosmetic treatment for acne, called Effaclar – La Roche Posay, a product you can find on Amazon with only 20$.
Acne has a significant psychological impact on people suffering from this disease. For more than 56% of people affected by acne, skin imperfections remain the main source of physical complexes.
In a scientific study published in British Journal of Dermatology, it was demonstrated that the psychological impact of acne was comparable to the one caused by chronic diseases like asthma, diabetes, arthritis and even epilepsy. Surprisingly, acne remains the main reason for dermatologists consultation, 1 of 4 patients who consult a dermatologist suffer from this disease.
Adolescents are the population segment most affected by acne: over 76% of teenagers aged between 11 and 18 years have acne representing 70% of patients consulting a dermatologist for acne. In addition – between teenagers – two specific types of acne lesions co-exist causing what doctors call mixed acne.
Treatment for mixed acne is very complex as it is necessary to combine two different products, with local implementation: one for injuries retention, another for inflammatory lesions. The treatment scheme is complex and-therefore – there is a risk that it will not be followed properly. For most patients – teenagers – is difficult to follow two different treatments in the same time.
Dermatologic-cosmetic product range Effaclar – La Roche Posay – the historical leader in pharmacies in treatments for skin with acne tendency – is now visibly improved with the new product – EFFACLAR DUO.
The new product – Anti-imperfections and correction purifying treatment – is a major innovation in mixed acne. Result of complex dermatological studies, the product was designed to act simultaneously on two symptoms of this type of acne:
For the first time, La Roche Posay Laboratories combined 4 dermatological active ingredients in a dermato-cosmetic product to act on the two manifestations of mixed acne.
The efficiency of DUO EFFACLAR was demonstrated through a controlled clinical trial conducted by dermatological laboratories La Roche-Posay.
They achieved these significant results after only 4 weeks of using the product: